Timur KÖSE, Nefise Ülkü KARABAY YAVAŞOĞLU, Altuğ YAVAŞOĞLU, Aylin BUHUR, Fatih OLTULU, Melih DAĞDEVİREN, Gökçe Ceren KUŞÇU, Çevik GÜREL

Mid-dose losartan mitigates diabetes-induced hepatic damage by regulating iNOS, eNOS, VEGF, and NF-κB expressions

Mid-dose losartan mitigates diabetes-induced hepatic damage by regulating iNOS, eNOS, VEGF, and NF-κB expressions

Turkish Journal of Medical Sciences

2019-Cilt: 49 - Sayı: 5

1582-1589

3021